Transcatheter aortic valve implantation (TAVI) has revolutionized the management of severe aortic stenosis in patients at high surgical risk. However, neurological events remain a concerning complication, with clinically apparent stroke occurring in as many as 9.1% of patients in the early postoperative period. 1, 2 Furthermore, the perioperative incidence of magnetic resonance imaging (MRI)-defined cerebral infarcts ranges from 58% to 91%. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The etiology of neurological injury associated with TAVI is multifactorial, but embolic phenomena arising from the procedure are understood to be primarily responsible. An analysis of embolic protection devices removed following TAVI procedures found that 99% of filters contained embolic debris, including thrombus, calcification, valve tissue, arterial wall, and foreign material. 2 Thus, embolic protection devices have become the "new frontier" of both TAVI-related and perioperative neuroprotection research.
As MRI-defined cerebral infarcts are common and can be objectively and specifically measured, they have become an accepted surrogate marker of perioperative cerebral embolization and a recommended primary end point to determine neuroprotection device efficacy. 13, 14 Although a number of studies have reported the incidence of these lesions following TAVI, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] few explore their anatomical distribution, which is essential for understanding emboli transport and the subsequent cerebral predilection for injury. Here, we used diffusion-weighted MRI (DWI) lesion number and volume to characterize the topographic pattern of cerebral ischemic lesions following the TAVI procedure. The distribution that we identified not only extends our understanding of the causative mechanisms of cerebrovascular injury but also allows us to assess the effectiveness of current neuroprotective strategies.
Materials and methods

Study design and patient selection
Prospective, consecutive screening was performed on all patients presenting to The Prince Charles Hospital in Brisbane, Australia, for isolated TAVI using the SAPIEN-XT (Edwards LifeSciences, Irvine, CA) via a transfemoral approach between January and December 2016. Each patient's suitability for TAVI was determined by a multidisciplinary "heart team," which included cardiologists (general, interventional, and imaging), a cardiothoracic surgeon, a cardiac anesthetist, and nursing staff, as per international guidelines. 15 In all patients, TAVI was performed under general anesthesia, induced with propofol and maintained with sevoflurane, neuromuscular blockade (cisatracurium or rocuronium), and an ultra-/ short-acting opioid (remifentanil or fentanyl). Depth of anesthesia was guided by Bispectral Analysis (BIS; Covidien, Dublin, Ireland).
Before subject recruitment or data collection, ethics approval was obtained from the hospital's Human Research Ethics Committee (HREC/12/QPCH/291). Informed consent was obtained from all participants prior to their enrolment in the study. All-comers were considered with exclusion criteria as follows: (1) preexisting neurological impairment, as defined by a modified Rankin score of ≥3 (ie, moderate disability, requiring some assistance, but able to mobilize independently); (2) previous cerebrovascular events (including stroke or transient ischemic attack [TIA]); (3) carotid artery stenosis N50% on duplex ultrasonography; (4) the presence of intracardiac thrombus identified on routinely performed preprocedure transesophageal echocardiograph; (5) any contraindication to MRI, including incompatible metallic prosthesis or foreign body, the inability to lie flat, or claustrophobia requiring sedation; (6) poor to absent English-speaking skills; and (7) prior aortic valve replacement.
Imaging
At baseline (within 24 hours prior to TAVI), an MRI of each patient's brain was obtained using a 1.5-T system (MAGNETOM Aera; Siemens Healthcare GmbH, Erlangen, Germany). These scans were used to assess cerebrovascular anatomy, identify significant intracranial stenosis, and grade degenerative changes in each patient. The Global Cortical Atrophy Scale was used to quantify the degree of cerebral atrophy 16 ; and the Fazekas scale, to quantify T2 hyperintense lesions in periventricular white matter and deep white matter. 17 Early follow-up MRI was performed on postprocedure day 3 ± 1, and those who sustained cerebral infarction were followed up with a repeat MRI at 6 ± 1 months. The imaging protocol for the baseline assessment was comprehensive, consisting of standard fast-spin echo sequences (T1-weighted and T2-weighted), DWI, apparent diffusion coefficient (ADC) mapping, susceptibility-weighted imaging (SWI), T2-weighted fluid-attenuated inversion recovery (FLAIR), and time of flight angiography of the circle of Willis to document any preexisting disease. The more limited follow-up scans comprised DWI, ADC, SWI, T2-weighted, T1-weighted, and FLAIR imaging. Cerebral ischemia was defined by DWI hyperintensity caused by the restricted diffusion of water with reciprocal hypointensity on ADC maps.
18 T1-weighted, T2-weighted, and FLAIR sequences were used to exclude other lesions that can mimic strokes. Lesions were quantified both by number and by volume, the latter using automated 3-dimensional reconstructions from planimetry obtained by manual contouring (OsiriX, Geneva, Switzerland). To analyze their topographical distribution, lesions were stratified based on the type of brain parenchyma involved, hemisphere, and vascular territory (Figure 1 ).
Clinical assessment
A detailed standardized medical history was obtained from each patient. Clinically apparent stroke was detected and localized using the National Institutes of Health Stroke Scale, whereas the modified Rankin scale was used to categorize stroke severity. These tests were administered within 24 hours prior to the TAVI procedure and again at 3 ± 1 days, 6 ± 1 weeks, and 6 ± 1 months post-TAVI.
Statistical analysis
The primary end point was new DWI-positive lesions on the postprocedure scan relative to baseline MRI, quantified by both number and volume (μL). 13, 18 Clinically apparent cerebrovascular events, including stroke (either major or minor) and TIA, were secondary end points. Summary statistics are presented as means ± SDs when the data were parametric or as medians ± interquartile ranges when nonparametric. Significance testing was performed for both (1) the null hypothesis (N 0 ) that distribution is equal (ie, 50:50 between anterior:posterior circulations [P 50:50 ]) and (2) the N 0 that the number of embolic lesions is proportional to blood flow, which is weighted 70:30 anterior:posterior circulations (P 70:30 ).
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Results
Patient and procedural characteristics
Forty patients were enrolled between January and December 2016 and are included in this analysis. A flowchart of patients throughout the study is shown in Figure 2 . Baseline patient and procedural characteristics are summarized in Table I . 15 
Neurologic outcomes
Baseline MRI. Given the advanced age and moderate to high risk of the study population, it is not surprising that a degree of global cerebral atrophy was identified in all patients on baseline MRI ( Figure 3 ). In 2 patients, a subacute supratentorial infarct was detected: one exhibited a deep white matter infarct and the other a cortical infarct. Convincing chronic MRI evidence of 7 prior infarctions was observed across 5 individuals. Focal SWI hypointensity was observed in the majority (32/40) of patients. A total of 90 lesions were identified, with a median of 2 ± 2.25 lesions per patient. In addition, SWI sequences identified gyriform superficial siderosis in 3 individuals and linear evidence of previous hemorrhagic change in an old infarct in another patient. One-quarter of the patients (10/40) had persistent fetal origins of their posterior cerebral arteries (PCAs), whereby the posterior communicating artery was greater in caliber than the ipsilateral P1 segment of the PCA. Incidental findings included a pituitary macroadenoma, a pontine cavernous angioma, a 4-mm right internal carotid artery aneurysm, and the recurrence of a meningioma resected approximately 2 decades earlier.
Postprocedural MRI. Of the 40 participants who underwent a baseline MRI and received a SAPIEN-XT valve, 31 were assessed for the primary end point ( Figure 2 ). We identified 83 new DWI-positive lesions across 19 of 31 (61%) patients, a median of 1 ± 2.8 lesions per patient, with a volume of 20 ± 190 μL per patient. In those 19 patients, typically more than 1 lesion was present (in 12/19 cases; 63%). The distribution characteristics of these lesions are presented in Table II and Figure 4 . Lesions typically involved the cortical gray matter by both number (50 lesions or 60%) and volume (9327 μL or 80%), and 49 (59%) occurred in the posterior circulation and 34 (41%) in the anterior circulation (P 50:50 = .2; P 70:30 b .0001). Similarly, when considering the total volume of infarction, 10,255 μL (90%) occurred in the posterior compared with 1,192 μL (10%) in the anterior circulation (P b .0001 for both N 0 ). By number, 43 (63%) lesions occurred in the right hemisphere versus 25 (37%) lesions on the left (P = .06), totaling volumes of 9250 μL (81%) and 2150 μL (19%), respectively (P b .0001). Importantly, cerebellar and brainstem lesions were not lateralized to the left or right, as such stratification would confound our understanding of the distribution of cardiogenic emboli traversing the aorta and branches.
Fifteen lesions demonstrated a T2-FLAIR or T1-weighted signal abnormality, which can be ascribed to the relatively small average infarct size to slice thickness. Four acute infarcts in 3 patients demonstrated new, associated SWI hypointensity consistent with hemorrhage. Eighteen new postprocedural SWI hypointensities were identified in 10 patients, with a maximum of 4 new lesions per patient. Superficial linear gyral SWI hypointensity suggestive of low-volume subarachnoid hemorrhage was identified in 1 patient.
Six-month MRI. All postprocedural DWI-positive lesions resolved by the 6-month MRI scan consistent with the natural evolution of DWI changes. Given the relatively small volumes of the infarcts, most lesions were no longer reliably detectable on T2-FLAIR or T1-weighted sequences. One individual demonstrated new SWI hypointensity at an infarct site, and 3 new SWI hypointensities were detected in another patient. A new linear superficial gyriform SWI hypointensity, consistent with blood products, was seen in a third individual. Finally, a new acute left-frontal, deep white matter infarct was identified in an individual with advanced background white matter changes at baseline.
Objective clinical assessments
No clinically apparent cerebrovascular events were detected.
Discussion
This analysis offers a unique opportunity to observe the distribution of cardiogenic microemboli and new ischemic lesions post-TAVI. We identified 83 new lesions across 19 of 31 (61%) participants, 80% of which by volume involved cortical gray matter, 90% occurred in the posterior circulation, and of those occurring in the anterior circulation, 81% were in the right hemisphere. This topographical distribution raises several procedural and physiological questions for consideration.
TAVI is associated with the frequent occurrence of cerebral ischemic lesions, with reported incidence rates ranging from 58% to 98%. [3] [4] [5] [6] [7] [8] [9] 19 The 61% incidence identified in this cohort is at the lower end of this range and could reflect the comparatively lower surgical risk of this sample and also the continual improvement in TAVI prostheses and procedures. 20 Indeed, the SAPIEN-XT valve used in this study has now largely been superseded by a newer-generation iteration, the SAPIEN-3, which has demonstrated lower risk for cerebral infarction generation. 2 Considering vascular territories, significantly greater cerebral infarction was observed in the posterior versus anterior circulation, with the PCA territory being the most vulnerable. This result is perhaps counterintuitive because emboli should favor arteries that receive the largest volume of blood. The anterior cerebral circulation is formed by branches of the internal carotid arteries and, in healthy awake patients, contributes approximately 70% of the brain's blood supply. 21 The remaining 30% of cerebral blood flow arises from the 2 vertebral arteries, and this is the major supply for the posterior cerebral circulation. Based on blood flow distribution, therefore, one-third of all cardiogenic emboli would be expected in the posterior circulation. Consistent with this, when considering all strokes, typically only 20%-25% of ischemic events occur in the posterior circulation. 22 Blood flow distribution during cerebrovascular stress is less clear. The influence of anesthesia is of particular relevance but is poorly characterized with limited studies presenting conflicting data. Indeed, its effect is likely to be heterogeneous depending on the exact drugs, dosage, and area of brain considered. Kaitsi et al 23 identified a global reduction in cerebral blood flow (propofol N sevoflurane in equianesthetic doses); however, significant dose-dependent regional differences were evident. For example, high doses (2 minimum alveolar concentration [MAC]) of sevoflurane concurrently caused noticeable increased cerebellar flow (38%) and reduced frontal flow (23%). Conversely, Rozet et al 24 using low-dose sevoflurane anesthesia (0.5 MAC) demonstrated that posterior circulation blood flow was reduced relative to the anterior circulation. ⁎ Based on the null hypothesis that emboli distribution is equal (ie, 50:50). † Based on the null hypothesis that emboli distribution is proportional to blood flow (which is weighted 70:30 anterior:posterior).
Inextricably linked to cerebral blood flow are the cerebral autoregulation and neurovascular coupling mechanisms that defend the brain against hemodynamic and metabolic disturbance. Impaired autoregulation may result in relative hyper-or hypoperfusion, either of which could be detrimental. Specifically, increased blood flow might deliver more emboli, whereas reduced blood flow could magnify the effects of microemboli by impairing their washout. 25 Thus, relatively impaired cerebral autoregulation in the posterior versus anterior circulation is a plausible explanation for the observed differences in vulnerability to injury. This is supported by the findings that (1) the posterior circulation has lower carbon dioxide reactivity than the anterior circulation 26 and (2) Figure 4 Anatomical distribution of MRI-defined cerebral infarctions in 3-dimensional views of the brain: A, Sagittal. B, Coronal. C, Axial. © Kayama Studios 2016.
Figure 3
Radiological grading of degenerative changes using the Global Cortical Atrophy Scale (Global Atrophy), and Fazekas scores for periventricular white matter (PVH) and deep white matter (DWM).
there is impaired dampening of arterial blood pressure oscillations in the posterior versus the anterior circulation. 27 Again, the role of anesthesia is unclear with Rozet et al 24 providing the only data and in only low-dose sevoflurane (0.5 MAC) anesthesia where cerebrovascular reactivity was maintained in both anterior and posterior circulations.
Anatomical differences also exist between the anterior and posterior circulations and may contribute to or explain some of the abovementioned physiological characteristics and vulnerability of the posterior circulation. Fluorescence microscopy of adult human brain tissue has identified differences in sympathetic innervation of the anterior versus posterior cerebral arteries with clear implication for vascular tone and autoregulatory capacity. 28 Furthermore, insult/injury may be exacerbated by intracranial atherosclerosis, which is more prone to occur in the posterior than anterior circulation, with the basilar artery being the single most common site. 29 The tortuous path of the vertebral arteries and acutely angled branches of the basilar artery might exacerbate this predilection further ( Figure 5) .
Alternatively, the distribution of cerebral infarcts may reflect differences in distribution of embolic load/insult rather than innate regional anatomical or physiological differences. Sophisticated modeling has shown a size-dependent trajectory for cardiogenic emboli reaching the carotid and vertebral arteries that varies distinctly from what is expected based on blood flow distribution. 30 In particular, the preponderance of small-to medium-sized cardiogenic particles reaching the branch arteries of the aortic arch, and subsequently the carotid and vertebral arteries, was markedly greater than that expected using volumetric flow. 30 However, further stratification of emboli between the carotid and vertebral arteries was not assessed.
A preponderance of clinically apparent infarctions in the posterior regions of the brain in patients undergoing cardiac surgery [31] [32] [33] [34] [35] and TAVI 3,4,7 has been noted previously, albeit not consistently. 5, [8] [9] [10] [11] Cassie et al 36 also documented this predilection experimentally. In a supine canine model and using an antifoam solution to perfuse the aorta, these investigators identified a significantly greater number of emboli and infarcts in the cerebellum, brainstem, and occipital lobes. 36 Logically, the effects of gravity must also be considered in supine patients who receive large doses (average 140 mL in our patient cohort) of iodinated radiocontrast during fluoroscopy. The density of radiocontrast used in this setting is greater than that of whole blood, a characteristic that is essential to its utility. Consequently, it is feasible that a contrast bolus might preferentially pool posteriorly in a supine patient, thereby reducing the oxygen-carrying capacity of the blood or drawing disproportionate emboli. However, this postulation is purely speculative.
In our patient cohort, the right hemisphere seemed to be more vulnerable than the left, accounting for 63% of the ischemic lesions by number (P 50:50 = .06; P 70:30 b .0001) and 81% by volume (P b .0001 for both N 0 ). This is contrary to other TAVI studies, in which lesions were predominately in the left cerebral hemisphere. 4, 6, 8, 9 The left-sided vulnerability observed in these early studies was proposed to result from exposure of the left common carotid to emboli dislodged from the aortic arch during the placement and use of catheters and associated devices. However, transcranial Doppler studies have reported the majority of embolic signals arising while the TAVI prosthesis is being positioned and implanted and have concluded that the major source of embolic burden is the aortic valve itself. 37 It is important to recognize that embolic signals as measured by transcranial Doppler in this study did not discriminate the nature or size of embolic material or indicate a threshold for emboli sufficient to cause infarction.
The right-sided vulnerability that we observe seems more logical because as cardiogenic emboli traverse the aortic arch, the innominate artery supplying the right hemisphere is the first to be encountered; thus, it is exposed to the total embolic load, whereas subsequent supra-aortic arch vessels are exposed to a lesser load. Furthermore, anatomically, the innominate artery is of larger caliber and traverses a course parallel to the ascending aorta, contrary to the left carotid artery, which is smaller and arises perpendicular to the aortic arch. 38 We identified 60% of the lesions by number and 80% by volume in the cortical gray matter. Although the threshold for ischemia is often considered and reported on a whole-brain basis, tissue-specific differences support increased vulnerability of gray over white matter. Perhaps most evident are differences in the cellular constituents and, therefore, metabolic requirements and blood flow, 39 as well as well-documented differences in neurochemical responses to ischemia. 40 MRI studies have also established a significantly lower ischemic threshold in gray versus white matter, with a cutoff for cerebral blood flow of 35 versus 20 mL/100 g/min (P b .0001) and a cerebral blood volume of 1.7 versus 1.2 mL/100 g, respectively (P b .0001). 41 Consequently, gray matter has greater blood flow and volume and a shorter mean transit time than white matter; thus, the former may be exposed to greater embolic loads and be more vulnerable to hypoperfusion.
The topographical distribution of new ischemic lesions that we observed has implications for neuroprotection during TAVI. Studies to date suggest that embolic protection devices represent a promising adjunct for improving the safety of TAVI. Recently published randomized controlled trials of the Sentinel Cerebral protection System (Claret Medical, Santa Rosa, CA) have shown a reduction in the volume of MRI-detected cerebral infarction in vascular territories protected by embolic protection devices, resulting in FDA approval. 2, 19, [42] [43] [44] However, this and other cerebral protection devices-for example, the Embrella embolic deflector system (Edwards Lifesciences Ltd, Irvine, CA)-are inefficient at protecting the left subclavian artery ( Figure 6 ). This is the origin of the left vertebral artery, which merges with the right vertebral artery to form the basilar artery-the major supply to the posterior portion of the circle of Willis ( Figure 5 ). Thus, embolic protection devices that lack coverage of the left subclavian artery also fail to completely protect the posterior circulation, resulting in 19 of 28 vascular territories and 26% of the brain volume being either partially or completely unprotected. 19 Our findings highlight this territory as one of the most vulnerable to ischemic lesions, suggesting that, although technically challenging, the development of embolic protection devices that offer full coverage of all 3 supra-aortic branches of the aortic arch may be beneficial.
Our study involved only a relatively small, nonrandomized patient cohort, and all the TAVI procedures were performed exclusively using the Edwards SAPIEN-XT prosthesis, limiting extrapolation of these findings to newer iterations of TAVI prostheses or other cardiac procedures. Furthermore, the risk stratum of our cohort was heterogeneous, with a mixture of intermediate-risk, high-risk, and inoperable participants. Although comparing differences in surgical risk strata is prudent, this was not possible for our cohort. The limited sample size and high incidence of DWI-positive lesions also affected our ability to perform more sophisticated logistic regression analysis. DWI and neurologic assessments were performed conscientiously; however, they were only possible in those patients able to tolerate them. Several of our TAVI patients were unable to undergo follow-up scans because of frailty, being medically unfit, or pacemaker insertion, which could have introduced further bias. Consequently, only 31 of 40 (78%) patients who underwent baseline assessment were followed up with the day 3 ± 1 scan, and of these, 21 of 31 (68%) underwent the 6-month MRI. Finally, interstudy methodological heterogeneity pervades this field of research and must be considered when placing this into the context of previous work.
Conclusions
Our understanding of periprocedural cardioembolic strokes that occur secondary to cardiac interventions is less developed than one might think, and a number of vital questions remain unanswered. In our cohort of patients undergoing TAVI, we identified the posterior circulation and the right hemisphere as particularly vulnerable to cerebral infarctions. These findings contrast with previous reports but are consistent with our knowledge of cardioembolic stroke in theoretical models and other cardiac procedures. Certainly, this has implications for risk-minimization strategies, particularly when evaluating protective devices designed to prevent the spread of emboli into the cerebral circulation. This is a pertinent issue given the extension of the TAVI procedure to lower-risk patients who have a longer life expectancy and thus more time for subclinical neurological injury to exert adverse effects.
